TrialPediatric blood & cancer2014

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).

Elizabeth Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.